CUPERTINO, CA – April 12, 2018 – Aemetis, Inc. (NASDAQ: AMTX) today announced that Universal Biofuels, the company’s India subsidiary, is producing glycerin at above nameplate capacity and demand for the product exceeds supply. The production capacity of the refined glycerin unit at the Kakinada plant is approximately 18,000 metric tonnes per year. The sale of glycerin is an important part of the company’s business strategy in India.
“Our glycerin refining facility in India is operating above nameplate capacity by importing crude glycerin from Argentina and other biodiesel production countries,” stated Eric McAfee, Chairman and CEO of Aemetis. “As our plant scales up biodiesel production using the new pre-treatment unit, the refined glycerin production unit has grown to be an important source of consistent revenues and contribution margins supplying the production of consumer and paint products in India.”
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.